• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Does triple-negative phenotype accurately identify basal-like tumour? An immunohistochemical analysis based on 143 'triple-negative' breast cancers.

作者信息

Bidard F-C, Conforti R, Boulet T, Michiels S, Delaloge S, André F

出版信息

Ann Oncol. 2007 Jul;18(7):1285-6. doi: 10.1093/annonc/mdm360.

DOI:10.1093/annonc/mdm360
PMID:17675400
Abstract
摘要

相似文献

1
Does triple-negative phenotype accurately identify basal-like tumour? An immunohistochemical analysis based on 143 'triple-negative' breast cancers.三阴性表型能否准确识别基底样肿瘤？基于143例“三阴性”乳腺癌的免疫组织化学分析。
Ann Oncol. 2007 Jul;18(7):1285-6. doi: 10.1093/annonc/mdm360.
2
Triple-negative breast cancer: current state of the art.三阴性乳腺癌：当前的技术水平
Tumori. 2010 Nov-Dec;96(6):875-88.
3
'Triple negative' epithelial ovarian cancer and pathologic markers for prognosis.三阴性上皮性卵巢癌和预后的病理标志物。
Curr Opin Obstet Gynecol. 2011 Feb;23(1):19-23. doi: 10.1097/GCO.0b013e32834252f5.
4
Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.三阴性乳腺癌中的大汗腺癌：大汗腺型浸润性导管癌为雌激素/孕激素受体阴性、雄激素受体阳性的新型定义。
Jpn J Clin Oncol. 2012 May;42(5):375-86. doi: 10.1093/jjco/hys034. Epub 2012 Mar 26.
5
IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype.IMP3是三阴性浸润性乳腺癌的一种新型生物标志物，与更具侵袭性的表型相关。
Hum Pathol. 2009 Nov;40(11):1528-33. doi: 10.1016/j.humpath.2009.05.005. Epub 2009 Aug 19.
6
Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers.癌症干细胞相关标志物 ALDH1 和 EZH2 在三阴性和基底样乳腺癌中的预后影响。
Pathology. 2012 Jun;44(4):303-12. doi: 10.1097/PAT.0b013e3283534bcb.
7
Basal cytokeratin and epidermal growth factor receptor expression are not predictive of BRCA1 mutation status in women with triple-negative breast cancers.基底细胞角蛋白和表皮生长因子受体的表达与三阴性乳腺癌女性的 BRCA1 突变状态无关。
Am J Surg Pathol. 2009 Jul;33(7):1093-7. doi: 10.1097/PAS.0b013e31819c1c93.
8
Basal-HER2 phenotype shows poorer survival than basal-like phenotype in hormone receptor-negative invasive breast cancers.在激素受体阴性浸润性乳腺癌中，基底-HER2表型的生存率低于基底样表型。
Hum Pathol. 2008 Feb;39(2):167-74. doi: 10.1016/j.humpath.2007.06.012. Epub 2007 Nov 28.
9
Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases.三阴性和 HER2 过表达型乳腺癌具有更高的颅内转移风险和更早的发生。
Eur J Cancer. 2009 Nov;45(16):2792-8. doi: 10.1016/j.ejca.2009.06.027. Epub 2009 Jul 28.
10
Pathological definition of triple negative breast cancer.三阴性乳腺癌的病理学定义。
Eur J Cancer. 2009 Sep;45 Suppl 1:5-10. doi: 10.1016/S0959-8049(09)70011-5.

引用本文的文献

1
Clinicopathological significance of Sox10 expression in triple-negative breast carcinoma.Sox10在三阴性乳腺癌中的临床病理意义
Transl Cancer Res. 2020 Sep;9(9):5603-5613. doi: 10.21037/tcr-20-2634.
2
Are Basal-Like and Non-Basal-Like Triple-Negative Breast Cancers Really Different?基底样和非基底样三阴性乳腺癌真的不同吗？
J Oncol. 2020 Mar 16;2020:4061063. doi: 10.1155/2020/4061063. eCollection 2020.
3
MFAP5 promotes basal-like breast cancer progression by activating the EMT program.MFAP5通过激活上皮-间质转化程序促进基底样乳腺癌进展。
Cell Biosci. 2019 Mar 7;9:24. doi: 10.1186/s13578-019-0284-0. eCollection 2019.
4
Bcl-2 expression and prognostic significance in feline invasive mammary carcinomas: a retrospective observational study.Bcl-2在猫浸润性乳腺癌中的表达及其预后意义：一项回顾性观察研究。
BMC Vet Res. 2019 Jan 10;15(1):25. doi: 10.1186/s12917-018-1772-x.
5
Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going.三阴性乳腺癌患者的新辅助治疗：我们目前的状况与未来的发展方向
Cancer Manag Res. 2018 Jan 15;10:91-103. doi: 10.2147/CMAR.S146658. eCollection 2018.
6
Role of Taxanes in Triple-Negative Breast Cancer: A Study From Tertiary Cancer Center in South India.紫杉烷类药物在三阴性乳腺癌中的作用：来自印度南部三级癌症中心的一项研究
World J Oncol. 2017 Aug;8(4):110-116. doi: 10.14740/wjon1054w. Epub 2017 Aug 27.
7
The expressions of NEDD9 and E-cadherin correlate with metastasis and poor prognosis in triple-negative breast cancer patients.NEDD9和E-钙黏蛋白的表达与三阴性乳腺癌患者的转移及不良预后相关。
Onco Targets Ther. 2016 Sep 19;9:5751-5759. doi: 10.2147/OTT.S113768. eCollection 2016.
8
c-Met and ERβ expression differences in basal-like and non-basal-like triple-negative breast cancer.基底样和非基底样三阴性乳腺癌中c-Met和ERβ的表达差异
Tumour Biol. 2016 Aug;37(8):11385-95. doi: 10.1007/s13277-016-5010-5. Epub 2016 Mar 11.
9
Stratification of Prognosis of Triple-Negative Breast Cancer Patients Using Combinatorial Biomarkers.使用组合生物标志物对三阴性乳腺癌患者的预后进行分层
PLoS One. 2016 Mar 1;11(3):e0149661. doi: 10.1371/journal.pone.0149661. eCollection 2016.
10
Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer.三阴性乳腺癌与非三阴性乳腺癌的临床病理特征及预后比较
J Cancer. 2016 Jan 1;7(2):167-73. doi: 10.7150/jca.10944. eCollection 2016.